Disease | multiple endocrine neoplasia type 1 |
Comorbidity | C1319315|colorectal adenocarcinoma |
Sentences | 1 |
PubMedID- 22811876 | Conclusions: although capecitabine and lapatinib is well tolerated, it is not an effective regimen in patients with refractory colorectal adenocarcinoma. |
Page: 1